Terms: = Lung cancer AND CHEK2, bA444G7, 11200, ENSG00000183765, O96017, RAD53, RP11-436C9_1, PP1425, LFS2, CHK2, HuCds1 AND Prognosis
12573 results:
1. Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.
Yang J; Liu Y; Geng Q; Wang B
Mol Biol Rep; 2024 May; 51(1):670. PubMed ID: 38787485
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
Taylor J; Dubois F; Bergot E; Levallet G
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38785155
[TBL] [Abstract] [Full Text] [Related]
4. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.
Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q
Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer.
Hao Y; Zhang X; Cui G; Qi X; Jiang Z; Yu L
Cancer Med; 2024 May; 13(10):e7296. PubMed ID: 38770671
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical Multi-features Analysis of Cystic lung Adenocarcinoma
and Construction of Invasive Risk Prediction Model].
Wang Q; Fu C; Wang K; Ren Q; Chen A; Xu X; Chen L; Zhu Q
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):266-275. PubMed ID: 38769829
[TBL] [Abstract] [Full Text] [Related]
7. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.
Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q
BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064
[TBL] [Abstract] [Full Text] [Related]
8. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
9. An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma.
Chu D; Chen L; Li W; Zhang H
Clin Exp Med; 2024 May; 24(1):104. PubMed ID: 38761234
[TBL] [Abstract] [Full Text] [Related]
10. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
Sun Y; Ma Q; Chen Y; Liao D; Kong F
Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
[TBL] [Abstract] [Full Text] [Related]
11. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
Xing X; Li L; Sun M; Zhu X; Feng Y
Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
[TBL] [Abstract] [Full Text] [Related]
12. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
13. Patterns of distant metastasis and survival outcomes in
Liu K; Huang AL; Chen XQ; Wu SG
Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
[TBL] [Abstract] [Full Text] [Related]
14. Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms.
Huang Z; Liang F; Wu J; Huang Z; Li Y; Huang X; Liu Z
BMC Pulm Med; 2024 May; 24(1):239. PubMed ID: 38750474
[TBL] [Abstract] [Full Text] [Related]
15. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
Dang J; Xu G; Guo G; Zhang H; Shang L
J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
[TBL] [Abstract] [Full Text] [Related]
16. Influence of malnutrition according to the glim criteria on the chemotherapy toxicities in patients with advanced lung cancer.
Li N; Xue D; Men K; Li L; Yang J; Jiang H; Meng Q; Zhang S
Support Care Cancer; 2024 May; 32(6):358. PubMed ID: 38750262
[TBL] [Abstract] [Full Text] [Related]
17. CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis.
Fu M; Feng C; Wang J; Guo C; Wang Y; Gao R; Wang J; Zhu Q; Zhang X; Qi J; Zhang Y; Bian Y; Wang Z; Fang Y; Cao L; Hong B; Wang H
Clin Exp Med; 2024 May; 24(1):99. PubMed ID: 38748269
[TBL] [Abstract] [Full Text] [Related]
18. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
19. [Effect of peripheral blood inflammatory indicators on the efficacy of immunotherapy in patients with advanced non-small cell lung cancer and chronic obstructive pulmonary disease].
Bi ZK; Xu Y; Guo L; Zhang WJ; You YT; Li JW; Zhao CL; Shan YF; Xia TT; Li YF; Xu Z; Fan Y; Bai L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1601-1609. PubMed ID: 38742347
[No Abstract] [Full Text] [Related]
20. Prediction of Prognostic Features Based on Neutrophil-Related Genes for lung Squamous Cell Carcinoma Reveals Immune Landscape and Drug Candidates.
Sili D; Nan Z
Rev Invest Clin; 2024; 76(2):116-131. PubMed ID: 38740381
[TBL] [Abstract] [Full Text] [Related]
[Next]
